Medical Devices & Diagnostics · LP-216
Urine test strips Diagnostic test
Device / diagnostic development record. Review the proposed presentation and the professional reference information below.
Development record
- Portfolio reference
- LP-216Medical Devices & Diagnostics
- Product type
- Urine test stripsDiagnostic test
- Registration
- Not establishedProduct-specific evidence required
- Availability
- Not marketedNo offer of supply
01 · Product-type reference
Record identity and reference background.
- Portfolio reference
- LP-216
- Product type
- Urine test strips
- Device presentation
- Diagnostic test
- Configuration / specification
- 10-parameter strips; 11-parameter strips
- Proposed pack
- Bottle 100 strips
- Portfolio category
- Medical Devices & Diagnostics
About Urine test strips
Urine test strips are in vitro diagnostic devices containing reagent areas for specified urine characteristics. Depending on the product, these may provide qualitative or semi-quantitative findings used in clinical assessment. A count of ten or eleven parameters does not identify the actual analytes or prove diagnostic performance. The strip is not a medicine and does not independently establish the cause of a urinary or systemic illness.
How to read this profile
Scientific information relates to the device or diagnostic type. It is not approved Luang Pharma labelling, a clinical recommendation, or evidence of equivalence to a referenced product. Multiple strengths or presentations represent separate proposed variants and must not be treated as interchangeable.
02 · Professional background
Scientific & clinical reference
Read the clinical context, selected safety considerations and presentation-specific information below.
Intended-use context
Urinalysis results are interpreted with symptoms, sample quality and other clinical or laboratory findings. A finding may need confirmation by microscopy, culture, blood testing or another method. For example, a screening result alone may not establish urinary infection or the need for an antibiotic. The catalogue does not define analyte thresholds, instrument compatibility, read timing or suitability for screening a particular patient population.
Important safety considerations
Old or contaminated samples, unsuitable collection, interfering substances and damaged reagents can produce misleading results. A negative result does not rule out all relevant disease. Reading time differs between reagent pads, so casual visual interpretation can cause error. Colour-vision limitations or use with an incompatible reader can also matter. Significant symptoms, including systemic illness or visible blood in urine, require appropriate assessment independently of the strip result.
These are selected considerations, not a complete list. Use the current instructions or approved label for the exact authorised product and seek appropriate professional advice.
Presentation, handling and storage
The source lists ten- and eleven-parameter strips without naming the analytes. Verify each parameter, measurement scale, specimen requirements, reader compatibility and intended professional or self-test use. No parameter list or accuracy percentage should be invented.
Follow the product instructions for storage, bottle closure, humidity control and the period after first opening. Use a suitable freshly collected specimen and the exact pad-specific reading times. Keep lot and expiry information available, and do not use discoloured or otherwise compromised strips.
Final composition, instructions, shelf life and storage conditions are not established by this portfolio entry. They must come from the controlled documentation for the specific product.
Points for professional review
Confirm assay identity, analyte-level performance, intended population and local authorization. Establish sample handling, user training and a pathway for confirmatory testing or discordant results.
03 · Product enquiry
Documentation & regulatory status
Evidence status
What is established — and what remains open
This record has received an editorial evidence-layer review. The review separates catalogue facts from unresolved product-specific fields and external context; it is not medical, regulatory or market-authorisation approval.
Layer 01
Controlled catalogue facts
- Device / diagnostic type
- Urine test strips
- Presentation
- Diagnostic test
- Catalogue configuration
- 10-parameter strips; 11-parameter strips
- Catalogue pack
- Bottle 100 strips
- Portfolio category
- Medical Devices & Diagnostics
Layer 02
Unresolved product-specific fields
- P024 — “10-parameter” and “11-parameter” do not identify the analytes, reagent chemistry, semi-quantitative ranges, read times, visual-versus-analyser interpretation, interference limits or exact intended use.
- No parameter list, CLIA status, diagnostic accuracy, reader compatibility or regulatory authorization is inferred from the parameter count.
- Approved indication, patient eligibility and dosing or test interpretation are not established by this portfolio record.
- Registration/authorization, manufacturing or site status, supply availability, storage conditions and shelf life remain product- and market-specific evidence items.
Layer 03
Attributed external context
- FDA 510(k) database: example 10-parameter urinalysis reagent stripsgovernment device-database example
These references provide scientific or regulatory context only. They are not Luang Pharma product labelling, registration, manufacturing evidence, equivalence evidence or confirmation of supply.
Layer 04
Documents required to close the record
- Exact urine-strip model/IFU specifying every analyte, chemistry/range, read time, visual/analyser method, interferences, storage/stability, performance and compatible reader(s) if any.
- Destination-market device/IVD classification and authorization/conformity evidence for the exact model; generic FDA/WHO references are not evidence for the Luang record.
- Model-specific quality/performance verification and current packaging/label artwork before any public certification, accuracy, sterility or compatibility claim.
- Manufacturing/supply-status evidence before any claim that the device is produced, stocked, registered or available through Luang Pharma.
For LP-216, identify the destination country, intended professional use, proposed presentation and the role of your organisation. The appropriate supply route and available documentation must be confirmed for that case.
- Confirm the legal entity, manufacturing site and authorised scope for the proposed supply chain.
- Confirm device classification, intended use, conformity evidence and local import requirements.
- Request relevant product information, specifications and supporting evidence through the company contact.
- Confirm storage, transport, traceability, complaints and safety-reporting responsibilities before any agreement.
The public catalogue extends beyond the initial planned facility modules. A listing does not mean that the dosage form is installed, qualified or licensed at Boten.
04 · External sources
Sources and further reading
External sources are provided for reference. Their authors do not endorse Luang Pharma, and another product’s authorisation does not transfer to this portfolio record. Source availability and wording can change.
Professional enquiries
Request product-specific evidence for LP-216.
State the exact presentation, organisation, destination and evidence needed. This public record is not an offer of supply.